Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents a broad range of infections, including those affecting the skin, bladder, and lungs. It also develops Nu-3, a topical antimicrobial for infected diabetic foot ulcers, which is in Phase 2b clinical trial. The company was formerly known as Lakewood-Amedex In...
Jun 25, 2026, 8:02 AM EDT - 3 days ago
2026-06-22T12:13:49.000Z - 6 days ago
Jun 22, 2026, 8:02 AM EDT - 6 days ago
2026-06-18T23:52:08.000Z - 10 days ago
Jun 16, 2026, 8:02 AM EDT - 12 days ago
2026-05-29T18:11:40.000Z - 4 weeks ago
2026-05-29T18:05:31.000Z - 4 weeks ago
2026-05-27T14:34:25.000Z - 4 weeks ago
May 27, 2026, 8:02 AM EDT - 4 weeks ago
2026-05-18T12:12:33.000Z - 5 weeks ago
May 18, 2026, 8:02 AM EDT - 5 weeks ago
May 12, 2026, 8:02 AM EDT - 6 weeks ago
2026-05-01T12:13:42.000Z - 2 months ago
Apr 28, 2026, 7:33 AM EDT - 2 months ago
ENVB
2026-04-27T13:56:19.000Z - 2 months ago
2026-04-27T13:44:15.000Z - 2 months ago
Apr 23, 2026, 10:42 AM EDT - 2 months ago
Jan 9, 2026, 5:38 PM EST - 6 months ago
Jan 9, 2026, 5:28 PM EST - 6 months ago
Jan 9, 2026, 3:33 PM EST - 6 months ago